NCT02444546
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +29 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Refractory Brain Neoplasm
Explore clinical trials studying Refractory Brain Neoplasm. Study availability and eligibility vary by location and protocol.
3 public trials
0 recruiting studies
Refractory Brain Neoplasm trial results
Active, Not Recruiting
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
NCT02359565
- Conditions
- Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +46 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
Active, Not Recruiting
Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
NCT02389309
- Conditions
- Advanced Malignant Solid Neoplasm, Brain Diseases, Brain Neoplasms, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States